Showing 19,801 - 19,820 results of 46,043 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 19801

    DataSheet_1_Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies.pdf by Jingli Lu (486220)

    Published 2019
    “…Fifty-two RCTs were included, and 12 did not report any events of ICI-associated diabetes.</p><p>Results: A meta-analysis of 40 trials was performed, which reported at least one diabetes-related event among 24,596 patients. …”
  2. 19802

    DataSheet_1_Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies.pdf by Jingli Lu (486220)

    Published 2019
    “…Fifty-two RCTs were included, and 12 did not report any events of ICI-associated diabetes.</p><p>Results: A meta-analysis of 40 trials was performed, which reported at least one diabetes-related event among 24,596 patients. …”
  3. 19803

    DataSheet_1_A CRISPR/Cas9-mediated screen identifies determinants of early plasma cell differentiation.docx by Ermeng Xiong (11176635)

    Published 2023
    “…Hdac1 knock-out led to strongly perturbed protein expression of antagonistic transcription factors that govern plasma cell versus B cell identity (by decreasing IRF4 and BLIMP1 and increasing BACH2 and PAX5).…”
  4. 19804

    Table_1_Relationship Between Dairy Products Intake and Risk of Endometriosis: A Systematic Review and Dose-Response Meta-Analysis.docx by Xiangying Qi (9989599)

    Published 2021
    “…Total dairy intake was inversely associated with the risk of endometriosis, and the risk of endometriosis tended to decrease with a decrease in the risk of endometriosis when dairy products intake was over 21 servings/week (RR 0.87, 95% CI 0.76–1.00; p<sub>non−linearity</sub> = 0.04). …”
  5. 19805

    Sacrifice Template Strategy to the Fabrication of a Self-Cleaning Nanofibrous Membrane for Efficient Crude Oil-in-Water Emulsion Separation with High Flux by Mingming Wu (268965)

    Published 2020
    “…However, most materials are extremely susceptible to pollution during oil–water separation, which drastically restricts their widespread applications. Herein, a momordica-charantia-like nanofibrous membrane (MCNM) with underwater superoleophobic performance was fabricated through a sacrifice template strategy by the electrospinning solution of zeolitic imidazolate framework-8 (ZIF-8) and polyacrylonitrile particles. …”
  6. 19806

    Dynamic variations of cell populations given distinct impacts of Aβ on M1 macrophages (the value of α<sub>13</sub>). by Ishwar K. Puri (358815)

    Published 2013
    “…<p>Variations in the (a) M<sub>1</sub>, (b) N<sub>d</sub> and (c) Aβ populations over 20 years for three values of α<sub>13</sub>  =  1× (black), 10× (red), and 50× (blue) the value reported in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015176#pone-0015176-t001" target="_blank">Table 1</a> for the path Aβ → M<sub>1</sub>. …”
  7. 19807
  8. 19808
  9. 19809

    Summary of correlations in previous studies. by Dan Kuang (136225)

    Published 2025
    “…Furthermore, the infection rates of SARS-CoV-2, as estimated by the model, ranged from 0.012% (P5-P95: 0.004% - 0.020%) at the lowest baseline to 3.27% (P5-P95: 1.23% - 5.69%) at the peak of the epidemic, with 15.1% (P5-P95: 5.65% - 26.2%) of individuals infected during the epidemic wave between March 4th and June 15th. …”
  10. 19810

    The characteristics of nine WWTPs. by Dan Kuang (136225)

    Published 2025
    “…Furthermore, the infection rates of SARS-CoV-2, as estimated by the model, ranged from 0.012% (P5-P95: 0.004% - 0.020%) at the lowest baseline to 3.27% (P5-P95: 1.23% - 5.69%) at the peak of the epidemic, with 15.1% (P5-P95: 5.65% - 26.2%) of individuals infected during the epidemic wave between March 4th and June 15th. …”
  11. 19811

    Oxa33, a novel inhibitor against GlmU<sub>Mtb</sub> binds at allosteric site of uridyltransferase domain. by Vijay Soni (816694)

    Published 2015
    “…<b>(F)</b> Superimposed view of GlmU<sub>Mtb</sub>-Oxa33 complex before (green) and after (orange) the simulation time period. Showing a partial closure of uridyltransferase site (decreased volume) thereby making it unavailable for its substrates for catalysis.…”
  12. 19812

    Table 1_Moderating effects of a healthy lifestyle on the association of pre-metabolic syndrome with multiple chronic disease comorbidities.docx by Youqiong Xu (18161893)

    Published 2025
    “…Adherence to a healthy lifestyle (favorable [OR = 0.69, 95%CI: 0.59–0.82] and extremely favorable [OR = 0.54, 95%CI: 0.43–0.68]) was associated with a reduced risk of multiple comorbidities, with a trend toward a decreased risk of multiple comorbidities as the number of healthy lifestyles increased (p < 0.001). …”
  13. 19813

    Women's Education Level, Maternal Health Facilities, Abortion Legislation and Maternal Deaths: A Natural Experiment in Chile from 1957 to 2007 by Elard Koch (166600)

    Published 2012
    “…</p> <h3>Results</h3><p>During the 50-year study period, the MMR decreased from 293.7 to 18.2/100,000 live births, a decrease of 93.8%. …”
  14. 19814

    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…Further studies are warranted to assess whether different types and administration routes of estrogen therapy could decrease the VTE risk in AMAB trans people over 37.5 years subjected to long-term therapy.…”
  15. 19815

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…Further studies are warranted to assess whether different types and administration routes of estrogen therapy could decrease the VTE risk in AMAB trans people over 37.5 years subjected to long-term therapy.…”
  16. 19816

    Brincidofovir is a robust replication inhibitor against African swine fever virus <i>in vivo</i> and <i>in vitro</i> by Shibang Guo (16022925)

    Published 2023
    “…Brincidofovir reduces ASFV replication in a dose-dependent manner (IC<sub>50</sub> = 2.76 nM) without cytotoxicity (CC<sub>50</sub> = 58 μM). …”
  17. 19817
  18. 19818

    image6_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The results of meta-analysis showed that compared with western medicine alone, combination of western medicine and Qishen Yiqi Dripping Pill can further increase the quotient of early diastolic mitral inflow velocity and late diastolic mitral inflow velocity (E/A) in patients with HFpEF [mean difference (MD) = 0.20, 95% CI (0.14, 0.26), p < 0.000 01], decrease the quotient of early diastolic mitral inflow velocity and mitral annular tissue velocity (E/e′) [MD = −2.50, 95% CI (−3.18, −1.82), p < 0.000 01], decrease brain natriuretic peptide (BNP) [MD = −151.83, 95% CI (−245.78, −57.89), p = 0.002], increase cardiac function improvement rate [relative risk (RR) = 1.30, 95% CI (1.11, 1.52), p = 0.001], and increase six-minutes walking distance (6-MWD) [MD = 64.75, 95% CI (22.65, 106.85), p = 0.003]. …”
  19. 19819

    image4_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.jpeg by Mengxi Wang (231051)

    Published 2021
    “…The results of meta-analysis showed that compared with western medicine alone, combination of western medicine and Qishen Yiqi Dripping Pill can further increase the quotient of early diastolic mitral inflow velocity and late diastolic mitral inflow velocity (E/A) in patients with HFpEF [mean difference (MD) = 0.20, 95% CI (0.14, 0.26), p < 0.000 01], decrease the quotient of early diastolic mitral inflow velocity and mitral annular tissue velocity (E/e′) [MD = −2.50, 95% CI (−3.18, −1.82), p < 0.000 01], decrease brain natriuretic peptide (BNP) [MD = −151.83, 95% CI (−245.78, −57.89), p = 0.002], increase cardiac function improvement rate [relative risk (RR) = 1.30, 95% CI (1.11, 1.52), p = 0.001], and increase six-minutes walking distance (6-MWD) [MD = 64.75, 95% CI (22.65, 106.85), p = 0.003]. …”
  20. 19820

    datasheet1_Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.doc by Mengxi Wang (231051)

    Published 2021
    “…The results of meta-analysis showed that compared with western medicine alone, combination of western medicine and Qishen Yiqi Dripping Pill can further increase the quotient of early diastolic mitral inflow velocity and late diastolic mitral inflow velocity (E/A) in patients with HFpEF [mean difference (MD) = 0.20, 95% CI (0.14, 0.26), p < 0.000 01], decrease the quotient of early diastolic mitral inflow velocity and mitral annular tissue velocity (E/e′) [MD = −2.50, 95% CI (−3.18, −1.82), p < 0.000 01], decrease brain natriuretic peptide (BNP) [MD = −151.83, 95% CI (−245.78, −57.89), p = 0.002], increase cardiac function improvement rate [relative risk (RR) = 1.30, 95% CI (1.11, 1.52), p = 0.001], and increase six-minutes walking distance (6-MWD) [MD = 64.75, 95% CI (22.65, 106.85), p = 0.003]. …”